How much does the Boston Scientific Securities Litigation Settlement pay?

The total settlement fund is $38.5M. Actual amounts depend on how many valid claims are filed — most settlements divide a fixed fund pro rata, so a higher claim rate means a smaller individual check. An "up to" figure is a cap, not a guarantee.

Is the Boston Scientific Securities Litigation Settlement notice real, or a scam?

JND Legal Administration is the settlement administrator for this case. Claims are filed at bostonscientificsecuritieslitigation.com. Filing a class action claim is always free — no legitimate settlement charges you to claim, and no administrator will ask for payment, a gift card, or your full Social Security number by email or text. If a notice asks for any of those, it is not from the administrator. When in doubt, ignore the link you were sent and go to the official settlement website directly.

When will payments from the Boston Scientific Securities Litigation Settlement be sent?

Class action payouts typically take 12 to 24 months after the claim deadline, and longer if the settlement is appealed. The final approval hearing for this case is set for April 23, 2024; no payments can be issued before a settlement receives final approval.

Claims closedsecurities

Boston Scientific Securities Litigation Settlement

Last verified September 18, 2026Source: jndHow ClaimWatch verifies cases

This settlement is closed to new claims. You can still see what it was about and follow the case in court below. Looking for money you can still claim? Browse open settlements →

What happened

Boston Scientific Corporation and certain executives were accused of making false and misleading statements regarding Boston Scientific's Lotus Edge medical device in violation of federal securities laws. The defendants have settled for $38.5 million in cash without admitting wrongdoing.

Do you qualify?

All persons or entities who purchased or otherwise acquired Boston Scientific common stock during the period from September 16, 2020 through November 16, 2020, inclusive, and were damaged thereby. Excluded are defendants, their immediate family members, company officers and directors, parent/subsidiary entities, and those with controlling interests.

How to file

Claims administration has been completed as of February 7, 2025. Distributions have already begun, with an initial distribution in April 2025 and a second distribution in February 2026. For more information, contact the Claims Administrator at 877-595-0084 or info@BostonScientificSecuritiesLitigation.com.

Common questions

How much does the Boston Scientific Securities Litigation Settlement pay?: The total settlement fund is $38.5M. Actual amounts depend on how many valid claims are filed — most settlements divide a fixed fund pro rata, so a higher claim rate means a smaller individual check. An "up to" figure is a cap, not a guarantee.
Is the Boston Scientific Securities Litigation Settlement notice real, or a scam?: JND Legal Administration is the settlement administrator for this case. Claims are filed at bostonscientificsecuritieslitigation.com. Filing a class action claim is always free — no legitimate settlement charges you to claim, and no administrator will ask for payment, a gift card, or your full Social Security number by email or text. If a notice asks for any of those, it is not from the administrator. When in doubt, ignore the link you were sent and go to the official settlement website directly.
When will payments from the Boston Scientific Securities Litigation Settlement be sent?: Class action payouts typically take 12 to 24 months after the claim deadline, and longer if the settlement is appealed. The final approval hearing for this case is set for April 23, 2024; no payments can be issued before a settlement receives final approval.

Who's involved

Plaintiffs

Enrique Jevons(Consolidated Plaintiff)
Mariano Errichiello

Defendants

Kevin Ballinger
Ian Meredith
Susan Vissers Lisa
Shawn McCarthy
Daniel J. Brennan
Joseph M. Fitzgerald
Michael F. Mahoney
Boston Scientific Corporation

Counsel for plaintiffs

Counsel for defendants

Parties and counsel from the public court docket. Listing an attorney here isn't an endorsement, and ClaimWatch isn't affiliated with any of them.

In the news

Headlines via NewsAPI. ClaimWatch isn't affiliated with these publications.

New to class actions?

This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.

Settlement fund: $38.5M
Class period: September 16, 2020 – November 16, 2020
Final hearing: April 23, 2024
Case: In re Boston Scientific Corporation Securities Litigation
Case number: 1:20-cv-12225-ADB
Court: U.S. District Court (District of Massachusetts, based on case number prefix)
Administrator: JND Legal Administration

Official settlement website →

Case status & court docket

Federal court in MassachusettsMore from Massachusetts

U.S. District Court (District of Massachusetts, based on case number prefix)

Case terminated April 23, 2024

February 26, 2025
Distribution to class
Judge Allison D. Burroughs: ORDER entered GRANTING 170 Motion for Disbursement of Funds. (CAM) (Entered: 02/26/2025)
February 14, 2025
Distribution to class
MEMORANDUM in Support re 170 MOTION for Disbursement of Funds [Lead Plaintiff's Unopposed Motion for Approval of Distribution Plan] filed by Union Asset Management Holding AG. (Attachments: # 1 Exhibit 1 - Levy v. Gutierrez, ECF Nos. 267-2, 271)(Graziano, Salvatore) (Entered: 02/14/2025)
April 16, 2024
Final approval
REPLY to Response to 156 MOTION for Settlement [Lead Plaintiff's Motion for Final Approval of Class Action Settlement and Plan of Allocation], 158 MOTION for Attorney Fees [Lead Counsel's Motion for Attorneys' Fees and Litigation Expenses] filed by Union Asset Management Holding AG. (Attachments: #
March 19, 2024
Final approval
DECLARATION re 156 MOTION for Settlement [Lead Plaintiff's Motion for Final Approval of Class Action Settlement and Plan of Allocation], 158 MOTION for Attorney Fees [Lead Counsel's Motion for Attorneys' Fees and Litigation Expenses] by Union Asset Management Holding AG. (Attachments: # 1 Exhibit 1

View the full court docket on CourtListener →

More securities settlements

View all →

October 16, 2026securities

Eagle Pharma Securities Litigation Settlement

Eagle Pharmaceuticals, Inc. is the subject of a securities litigation class action. Shareholders who purchased the company's publicly traded common stock between August 9, 2022 and October 1, 2024 allege claims covered by this settlement, which the defendant has agreed to settle.

…more

December 5, 2026securities

Hut 8 Corp. Securities Class Action Settlement

Hut 8 Corp. and individual defendants are accused of alleged securities violations. The company and defendants have agreed to settle claims from investors who purchased securities during the class period without admitting wrongdoing.

December 10, 2026securities

Kornit Digital Ltd. Securities Litigation Settlement

Kornit Digital Ltd. and its executives are accused of securities fraud in this class action lawsuit. The defendants have denied all claims and admit no wrongdoing, but have agreed to settle the case for $19.5 million to eliminate the burden and expense of continued litigation.

…more